Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban

BACKGROUND: Reducing major bleeding events is a challenge when managing anticoagulation in patients with atrial fibrillation. This study evaluated the impact of modifiable and nonmodifiable bleeding risk factors in patients with atrial fibrillation receiving rivaroxaban and estimated the impact of r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Kirchhof, Paulus, Haas, Sylvia, Amarenco, Pierre, Hess, Susanne, Lambelet, Marc, van Eickels, Martin, Turpie, Alexander G. G., Camm, A. John
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335544/
https://ncbi.nlm.nih.gov/pubmed/32079476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009530
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados